Radioprotection, pharmacokinetic and behavioural studies in mouse implanted with biodegradable drug (amifostine) pellets

International Journal of Radiation Biology

Volumn 78, Issue 6, 2002, Pages 535-543

  Srinivasan, V ^a   Pendergrass Jr , J A ^a   Kumar, K S ^a   Landauer, M R ^a   Seed, T M ^a  

^a ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; COBALT 60;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG IMPLANTATION; GAMMA RADIATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION PROTECTION;

AMIFOSTINE; ANIMALS; DRUG IMPLANTS; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MOTOR ACTIVITY; RADIATION-PROTECTIVE AGENTS;

ANIMALIA;

EID: 0036094568     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530002317577358     Document Type: Article

References (25)

1. Future developments of amifostine in cancer treatment
2. Dehydroepiandrosterone functions as more than an antiglucocorticoid in preserving immunocompetence after thermal injury
3. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine
4. Biological characteristics of some improved radioprotectors
5. Radioprotective ethylcellulose microspheres containing WR-2721, after oran administration
6. Amifostine pretreatment for protection against cyclophosphamide-induced and cis-plantin-induced toxicities: Results of a randomized control trial in patients with advanced ovarian cancer
7. Toxicity of WR-2721 administered in single and multiple doses
8. Pharmacokinetics of amifostine and its metabolites in patients
9. Radioprotective and hemodynamic effects of WR-2721 and cystamine in rats: Time course studies
10. Transdermal absorption of radioprotectors in the rat using permeation-enhancing vehicles
11. Dose and time relationships of the radioprotector WR-2721 on locomotor activity in mice
12. Behavioral toxicity of selected radioprotectors
13. New methods of drug delivery
14. Review of transmucosal drug delivery
15. Clinical evaluation of Norplant in Kumasi, Ghana
16. A method for the routine assessment of fore- and hind-limb grip strength of rats and mice
17. Biocompatibility issue of implantable drug delivery systems
18. HPLC/EC method for quantifying WR-1065 and WR-33278
19. Hypotensive mechanisms of amifostine
20. A controlled-release microchip
21. Pharmacokinetics of amifostine: Effects of dose and method of administration
22. Transdermal absorption of radioprotectors using permeation-enhancing vehicles
23. Radioprotection by vitamin E: Injectable vitamin E administered alone or with WR-3689 enhances survival of irradiated mice
24. Advances in radioprotection through the use of combined agent regimens
25. Cisplatin delivery by biodegradable polymer implant is superior to systemic delivery by osmotic pump or intraperitoneal injection in tumor bearing mice